Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNRHR | P30968 | 20/20 | 1.00 |
| ▸ | FPR1 | P21462 | 1/20 | 1.00 |
| ▸ | GPR183 | P32249 | 1/20 | 1.00 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31060713 | 1.00 | GNRHR (1.00) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL5834658 | 0.90 | GNRHR (0.82) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL5835109 | 0.89 | GNRHR (0.81) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL6224065 | 0.85 | GNRHR (0.75) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL17549863 | 0.83 | GNRHR (0.71) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL17549867 | 0.83 | GNRHR (0.71) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL5266205 | 0.83 | GNRHR (0.71) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL5705276 | 0.83 | GNRHR (0.71) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL17552170 | 0.82 | GNRHR (0.70) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL16238424 | 0.82 | GNRHR (0.70) | GNRHRFPR1GPR183GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116693484-B | Simple synthesis method of 1-bromodibenzofuran | 武汉理工大学 | 2024-11-12 | — | — | CN | claimed |
| CN-115947704-B | Preparation method of organic luminescent material intermediate 1-bromodibenzofuran | 武汉理工大学深圳研究院 | 2024-04-09 | — | — | CN | claimed |
| CN-115677637-B | Simple preparation method of 1-bromodibenzofuran | 安徽秀朗新材料科技有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-116693484-A | Simple synthesis method of 1-bromodibenzofuran | 武汉理工大学 | 2023-09-05 | — | — | CN | claimed |
| CN-115947704-A | Preparation method of organic luminescent material intermediate 1-bromodibenzofuran | 武汉理工大学深圳研究院 | 2023-04-11 | — | — | CN | claimed |
| CN-115677637-A | Simple preparation method of 1-bromodibenzofuran | 萍乡学院 | 2023-02-03 | — | — | CN | claimed |
| WO-2022208382-A1 | NOVEL DIALKOXYNAPHTHO[2,3-C]FURAN-1(3H)-ONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASE OR SARS-COV-2 INFECTION DISEASE, COMPRISING SAME | 동화약품주식회사 | 2022-10-06 | — | — | WO | claimed |
| CN-114129584-A | Application of phillyrin, phillyrin derivatives and composition of phillyrin and forsythiaside in resisting cytomegalovirus | 富力 | 2022-03-04 | — | — | CN | claimed |
| CN-122005489-A | FACOD@DSPE nano particle, preparation method and application thereof in antibiosis/sterilization | 广西中医药大学第一附属医院(广西中医医院) | 2026-05-12 | — | — | CN | disclosed |
| US-12551490-B2 | Heterocyclic modulators of lipid synthesis | SAGIMET BIOSCIENCES INC. (US) | 2026-02-17 | — | — | US | disclosed |
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-12-25 | — | — | US | disclosed |
| WO-2025233259-A1 | COMPOUND FOR USE IN THE TREATMENT OF DEPRESSION, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER AND/OR BORDERLINE PERSONALITY DISORDER | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-11-13 | — | — | WO | disclosed |
| EP-3789389-B1 | CRYSTALLINE FORM OF (S)-N-[5-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSULFONYL)ETHYL]-4,6-DIOXO-5,6-DIHYDRO-4H-THIENO[3,4-C]PYRROLE-1-YL]ACETAMIDE | TIANJIN HEMAY PHARMACEUTICAL CO LTD (CN) | 2025-10-08 | — | — | EP | disclosed |
| EP-4611741-A1 | TARGETING ALLOSTERIC AND ORTHOSTERIC POCKETS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | Petra Pharma Corporation (US) | 2025-09-10 | — | — | EP | disclosed |
| US-20050250793-A1 | Preventives/remedies for hot flash | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-11-10 | — | — | US | disclosed |
| US-20050214330-A1 | Process for producing sustained-release composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2005-09-29 | — | — | US | disclosed |
| EP-1532985-A1 | PROCESS FOR PRODUCING SUSTAINED-RELEASE COMPOSITION | Takeda Pharmaceutical Company Limited (JP) | 2005-05-25 | — | — | EP | disclosed |
| EP-1495768-A1 | PREVENTIVES/REMEDIES FOR HOTFLASH | Takeda Pharmaceutical Company Limited (JP) | 2005-01-12 | — | — | EP | disclosed |
| US-20040235748-A1 | AGENTS FOR PREVENTING POSTOPERATIVE RECURRENCE OF PREMENOPAUSAL BREAST CANCER | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-11-25 | — | — | US | disclosed |
| EP-1382350-A1 | PREVENTIVES FOR POSTOPERATIVE RECURRENCE OF PREMENOPAUSAL BREAST CANCER | Takeda Chemical Industries, Ltd. (JP) | 2004-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235748-A1 | AGENTS FOR PREVENTING POSTOPERATIVE RECURRENCE OF PREMENOPAUSAL BREAST CANCER | GNRHR, BRCA1, SHBG | GNRHR 1/4885FPR1 1137/4885GPR183 165/4885 |
| US-20050250793-A1 | Preventives/remedies for hot flash | GNRHR, SHBG, FSHR | GNRHR 1/4885FPR1 774/4885GPR183 317/4885 |
| US-12551490-B2 | Heterocyclic modulators of lipid synthesis | FASN, FADS1, FADS2 | GNRHR 3928/4885FPR1 245/4885GPR183 1309/4885 |
| US-20050214330-A1 | Process for producing sustained-release composition | FIBP, PGF, GHRHR | GNRHR 94/4885FPR1 1302/4885GPR183 1533/4885 |
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | CD4, ICOS, CD69 | GNRHR 1250/4885FPR1 990/4885GPR183 2723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.